Bruton's Tyrosine Kinase Inhibitors: Approaches to Potent and Selective Inhibition, Preclinical and Clinical Evaluation for Inflammatory Diseases and B Cell Malignancies

被引：78

作者：

Lou, Yan ^{[1
]}

Owens, Timothy D. ^{[1
]}

Kuglstatter, Andreas ^{[1
]}

Kondru, Rama K. ^{[1
]}

Goldstein, David M. ^{[1
]}

机构：

[1] Hoffmann La Roche Inc, Discovery Chem, Small Mol Res, pRED,Pharma Res & Early Dev, Nutley, NJ 07110 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2012年 / 55卷 / 10期

关键词：

X-LINKED AGAMMAGLOBULINEMIA; CRYSTAL-STRUCTURES; DRUG DESIGN; SRC FAMILY; BTK; ACTIVATION; ARTHRITIS; DASATINIB; MECHANISM; INSIGHTS;

D O I：

10.1021/jm300035p

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：4539 / 4550

页数：12

共 80 条

[11]

Clinical Trials.gov, 2005, NCT01659255, Patent No. [2005014599, 2005/014599]

[12]

ClinicalTrials.gov. Safety and Efficacy Study of Bruton's Tyrosine Kinase Inhibitor in Subjects with Relapsed or Refractory Diffuse Large B-Cell Lymphoma, SAF EFF STUD BRUT TY

[13]

ClinicalTrials. gov. Safety and Tolerability Study of PCI-32765 Combined with Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendarnustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL), 2011, SAF TOL STUD PCI 327

[14] Primary B Cell Immunodeficiencies: Comparisons and Contrasts [J].

Conley, Mary Ellen ;

Dobbs, A. Kerry ;

Farmer, Dana M. ;

Kilic, Sebnem ;

Paris, Kenneth ;

Grigoriadou, Sofia ;

Coustan-Smith, Elaine ;

Howard, Vanessa ;

Campana, Dario .

ANNUAL REVIEW OF IMMUNOLOGY, 2009, 27 :199-227

[15] Structural biology contributions to tyrosine kinase drug discovery [J].

Cowan-Jacob, Sandra W. ;

Moebitz, Henrik ;

Fabbro, Doriano .

CURRENT OPINION IN CELL BIOLOGY, 2009, 21 (02) :280-287

[16]

Currie K. S., 2010, EFMC 21 INT S MED CH

[17] Targeting B-cells in Inflammatory Disease [J].

Currie, Kevin S. .

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 45, 2010, 45 :175-190

[18] Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma [J].

Davis, R. Eric ;

Ngo, Vu N. ;

Lenz, Georg ;

Tolar, Pavel ;

Young, Ryan M. ;

Romesser, Paul B. ;

Kohlhammer, Holger ;

Lamy, Laurence ;

Zhao, Hong ;

Yang, Yandan ;

Xu, Weihong ;

Shaffer, Arthur L. ;

Wright, George ;

Xiao, Wenming ;

Powell, John ;

Jiang, Jian-Kang ;

Thomas, Craig J. ;

Rosenwald, Andreas ;

Ott, German ;

Muller-Hermelink, Hans Konrad ;

Gascoyne, Randy D. ;

Connors, Joseph M. ;

Johnson, Nathalie A. ;

Rimsza, Lisa M. ;

Campo, Elias ;

Jaffe, Elaine S. ;

Wilson, Wyndham H. ;

Delabie, Jan ;

Smeland, Erlend B. ;

Fisher, Richard I. ;

Braziel, Rita M. ;

Tubbs, Raymond R. ;

Cook, J. R. ;

Weisenburger, Dennis D. ;

Chan, Wing C. ;

Pierce, Susan K. ;

Staudt, Louis M. .

NATURE, 2010, 463 (7277) :88-U97

[19] The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia [J].

de Rooij, Martin F. M. ;

Kuil, Annemieke ;

Geest, Christian R. ;

Eldering, Eric ;

Chang, Betty Y. ;

Buggy, Joseph J. ;

Pals, Steven T. ;

Spaargaren, Marcel .

BLOOD, 2012, 119 (11) :2590-2594

[20]

Dewdney N. J., 2009, US Patent, Patent No. [20090105209 A1, 20090105209]

← 1 2 3 4 5 6 7 8 →